openPR Logo
Press release

New drugs for Spinal Cord Injury excite: Key takeaway from Assessment Analysis

03-04-2020 06:39 PM CET | Health & Medicine

Press release from: HTF Market Intelligence Consulting Pvt. Ltd.

Spinal Cord Injury

Spinal Cord Injury

HTF Market Intelligence released a new research report of 209 pages on title 'Spinal Cord Injury - Pipeline Review, H2 2019' with detailed analysis, forecast and strategies. The study covers key regions and important players such as AbbVie Inc, Algiax Pharmaceuticals GmbH, Aposcience AG etc.

Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/2361031-spinal-cord-injury-pipeline-review

Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury - Pipeline Review, H2 2019, provides an overview of the Spinal Cord Injury (Central Nervous System) pipeline landscape.

Spinal cord injury (SCI) is defined as damage or trauma caused to the spinal cord. SCI can lead to loss or impaired function resulting in reduced mobility or feeling. It is usually caused by trauma, transverse myelitis, polio, spina bifida or Friedreich's ataxia. Signs and symptoms of spinal cord injury include extreme back pain or pressure in the neck, head or back, paralysis in any part of the body, numbness, tingling or loss of sensation in the hands, fingers, feet or toes, loss of bladder or bowel control, difficulty in walking and impaired breathing after injury.

Companies Mentioned in the Report
AbbVie Inc, Algiax Pharmaceuticals GmbH, Aposcience AG, Athersys Inc, BioAxone BioSciences Inc, Cellatoz Therapeutics Inc, CellCure, CSL Ltd, CSPC Pharmaceutical Group Ltd, Daewoong Pharmaceutical Co Ltd, EUSOL Biotech Co Ltd, Fortuna Fix Inc, GABA Therapeutics Inc, GNT Pharma Co Ltd, Helixmith Co Ltd, Hemostemix Inc, Hibernaid Inc, Histocell SL, Hope Biosciences LLC, K-Stemcell Co Ltd, Kringle Pharma Inc, Lineage Cell Therapeutics Inc, Mapreg SAS, Mitsubishi Tanabe Pharma Corp, NervGen Pharma Corp, NeuExcell Therapeutics Inc, Neuronax SAS, Neuroplast BV, New World Laboratories Inc, Novago Therapeutics AG, Novartis AG, Novoron Bioscience Inc, NuNerve Pty Ltd, PharmatrophiX Inc, Pharmazz Inc, Pharmicell Co Ltd, PixarBio Corp, Q Therapeutics Inc, Radikal Therapeutics Inc, RDD Pharma Ltd, ReNetX Bio, RespireRx Pharmaceuticals Inc, SanBio Inc, Seneca Biopharma Inc, StemCyte Inc, Stemedica Cell Technologies Inc, Sumitomo Dainippon Pharma Co Ltd, TechnoPhage SA, Tumorend LLC, Xcelthera INC, ZyVersa Therapeutics Inc

Request a sample report @ https://www.htfmarketreport.com/sample-report/2361031-spinal-cord-injury-pipeline-review

Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Spinal Cord Injury - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Spinal Cord Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Spinal Cord Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Cord Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 3, 7, 10, 3, 30 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 1, 2 and 14 molecules, respectively.

Spinal Cord Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Spinal Cord Injury (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Spinal Cord Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Spinal Cord Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Spinal Cord Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Spinal Cord Injury (Central Nervous System)

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Spinal Cord Injury (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Spinal Cord Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2361031-spinal-cord-injury-pipeline-review

Table of Contents
Introduction
Spinal Cord Injury - Overview
Spinal Cord Injury - Therapeutics Development
Spinal Cord Injury - Therapeutics Assessment
Spinal Cord Injury - Companies Involved in Therapeutics Development
Spinal Cord Injury - Drug Profiles
Spinal Cord Injury - Dormant Projects
Spinal Cord Injury - Discontinued Products
Spinal Cord Injury - Product Development Milestones
Appendix List of Tables
....Continued

Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=2361031

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA - 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the "Accurate Forecast" in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their "Goals & Objectives".

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New drugs for Spinal Cord Injury excite: Key takeaway from Assessment Analysis here

News-ID: 1954959 • Views:

More Releases from HTF Market Intelligence Consulting Pvt. Ltd.

Tech-Smart Choice Market Is Booming Worldwide | Major Giants Oracle, Salesforce, Zoom
Tech-Smart Choice Market Is Booming Worldwide | Major Giants Oracle, Salesforce, …
HTF MI recently introduced Global Tech-Smart Choice Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Tech-Smart Choice Market are: Google, Amazon, Microsoft, Apple, Dell, HP, Lenovo, ASUS, Xiaomi, OnePlus, Huawei, Samsung, Intel, AMD, NVIDIA,
Advanced Design Market Is Booming Worldwide | Major Giants Philips, Sony, Samsung
Advanced Design Market Is Booming Worldwide | Major Giants Philips, Sony, Samsun …
HTF MI recently introduced Global Advanced Design Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Advanced Design Market are: Dyson, IKEA, Philips, Sony, Samsung, ASUS, Tesla, Microsoft (Surface), GoPro, Bose, Dell, HP, Lenovo, Herman
Premium Quality Products Market Is Booming Worldwide | Major Giants Louis Vuitton, Gucci, Chanel
Premium Quality Products Market Is Booming Worldwide | Major Giants Louis Vuitto …
HTF MI recently introduced Global Premium Quality Products Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Premium Quality Products Market are: Apple (luxury devices), Rolex, Louis Vuitton, Gucci, Chanel, Hermès, Ferrari, BMW, Mercedes-Benz, Audi,
Customer Favorites Market Is Booming Worldwide | Major Giants Coca-Cola, Starbucks, McDonald's
Customer Favorites Market Is Booming Worldwide | Major Giants Coca-Cola, Starbuc …
HTF MI recently introduced Global Customer Favorites Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Customer Favorites Market are: Nike, Adidas, Puma, L'Oréal, Estée Lauder, Coca-Cola, Starbucks, McDonald's, Kellogg's, Mondelez International, PepsiCo, H&M, Zara

All 5 Releases


More Releases for Spinal

Evolving Market Trends In The Spinal Fusion Devices Industry: Advancements In Sp …
The Spinal Fusion Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]._x000D_ _x000D_ What Is the Expected Spinal Fusion Devices Market Size During the Forecast Period?_x000D_ Over the past few years, there has been a significant growth in the spinal fusion devices market. The market is projected
Key Influencer in the Spinal Fusion Devices Market 2025: Rising Spinal Disorder …
What Is the Forecasted Market Size and Growth Rate for the Spinal Fusion Devices Market? The market for spinal fusion devices has experienced significant growth in the past couple of years. Expectations are that it will rise from estimates of $7.85 billion in 2024 to approximately $8.31 billion in 2025, giving us a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this notable expansion during the historical period can
Disposable Spinal Instrument Market: Revolutionizing Spinal Surgery with Hygiene …
Introduction The medical device market has witnessed a surge in demand for disposable instruments, especially in areas where hygiene, precision, and efficiency are paramount. One such sector experiencing rapid growth is the disposable spinal instrument market. Spinal surgeries, being intricate and requiring high precision, have traditionally relied on reusable instruments. However, growing concerns about hygiene, infection control, and surgical efficiency have accelerated the shift toward disposable spinal instruments. These devices not
Endoscopic Spinal Surgery Market: Minimally Invasive Solutions for Spinal Disord …
Global Endoscopic Spinal Surgery Market size was valued at US$ 667 Mn. in 2022 and the total revenue is expected to grow at a CAGR of 7.9% through 2022 to 2029, reaching nearly US$ 1137 Mn. Endoscopic Spinal Surgery Market Overview: Maximize Market Research is a research firm that has published a detailed analysis of the "Endoscopic Spinal Surgery Market". MMR in-depth market assessments in research reports consider significant technological advancements in
Spinal Resilience: Acute Spinal Cord Injury Drug Pipeline Landscape (2023)
Market Outlook: Charting Progress: Acute Spinal Cord Injury Drug Pipeline Landscape (2023) The Acute Spinal Cord Injury Drug Pipeline Landscape sets its sights on a decade of advancements poised to redefine the trajectory of spinal resilience. This comprehensive outlook explores the unfolding strategies, innovations, and breakthroughs that promise to revolutionize the landscape of acute spinal cord injury treatment. Market Drivers: Neuroregeneration on the Horizon: At the forefront of the Acute Spinal Cord Injury Drug
Spinal Laminoplasty Market - Revolutionizing spinal care with minimally invasive …
Newark, New Castle, USA: The "Spinal Laminoplasty Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Spinal Laminoplasty Market: https://www.growthplusreports.com/report/spinal-laminoplasty-market/8601 This latest report researches the industry structure, sales, revenue,